D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
PUT
Cheesecake Factory
CAKE
$4.21B
| $366K | ﹤0.01% |
7,600
-8,300
| -52% | -$399K |
|
3002
First Financial Bankshares
FFIN
$4.97B
| $366K | ﹤0.01% |
15,808
-17,874
| -53% | -$420K |
|
3003
PUT
Best Buy
BBY
$18B
| $364K | ﹤0.01% |
+5,200
| New | +$374K |
|
3004
Ascendis Pharma A/S
ASND
$16.7B
| $362K | ﹤0.01% |
+5,542
| New | +$311K |
|
|
MZTI
3005
The Marzetti Company
MZTI
$2.94B
| $362K | ﹤0.01% |
2,938
-70
| -2% | -$8.64K |
|
|
NVRO
3006
DELISTED
NEVRO CORP.
NVRO
| $362K | ﹤0.01% |
+4,172
| New | +$337K |
|
|
GPOR
3007
CALL
DELISTED
Gulfport Energy Corp.
GPOR
| $362K | ﹤0.01% |
37,500
+10,000
| +36% | +$107K |
|
3008
Fate Therapeutics
FATE
$281M
| $359K | ﹤0.01% |
+36,796
| New | +$352K |
|
3009
Lincoln Electric
LECO
$13.8B
| $359K | ﹤0.01% |
3,986
+1,109
| +39% | +$103K |
|
|
RDUS
3010
PUT
DELISTED
Radius Health, Inc.
RDUS
| $359K | ﹤0.01% |
10,000
| – | – |
|
|
TRIB
3011
Trinity Biotech
TRIB
$5.7M
| $358K | ﹤0.01% |
464
| – | – |
|
|
CETV
3012
DELISTED
Central European Media Enterprises Ltd
CETV
| $358K | ﹤0.01% |
85,177
-18,115
| -18% | -$82K |
|
|
GOV
3013
PUT
DELISTED
Government Properties Income Trust
GOV
| $358K | ﹤0.01% |
+26,200
| New | +$413K |
|
3014
Immersion
IMMR
$216M
| $356K | ﹤0.01% |
29,800
-733
| -2% | -$7.43K |
|
3015
ScottsMiracle-Gro
SMG
$4.03B
| $356K | ﹤0.01% |
4,152
-11,336
| -73% | -$1.08M |
|
3016
PUT
First Solar
FSLR
$21.8B
| $355K | ﹤0.01% |
5,000
-93,900
| -95% | -$6.39M |
|
3017
Peoples Bancorp
PEBO
$1.45B
| $355K | ﹤0.01% |
10,021
-2,761
| -22% | -$96.5K |
|
|
LNW
3018
PUT
DELISTED
Light & Wonder
LNW
| $354K | ﹤0.01% |
8,500
-29,400
| -78% | -$1.38M |
|
|
TRTX
3019
TPG RE Finance Trust
TRTX
$666M
| $353K | ﹤0.01% |
17,772
-6,266
| -26% | -$120K |
|
|
AVHI
3020
DELISTED
A V Homes, Inc.
AVHI
| $353K | ﹤0.01% |
19,020
+1,737
| +10% | +$30.6K |
|
|
ADAP
3021
DELISTED
Adaptimmune Therapeutics
ADAP
| $352K | ﹤0.01% |
31,367
-50,253
| -62% | -$440K |
|
3022
PUT
Automatic Data Processing
ADP
$100B
| $352K | ﹤0.01% |
3,100
| – | – |
|
3023
Forestar Group
FOR
$1.44B
| $352K | ﹤0.01% |
+16,624
| New | +$386K |
|
3024
National CineMedia
NCMI
$354M
| $352K | ﹤0.01% |
+6,784
| New | +$448K |
|
|
DRD
3025
DRDGold
DRD
$1.82B
| $351K | ﹤0.01% |
128,627
-6,155
| -5% | -$18.5K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.